Guardant Health, Inc., a leading precision oncology company, has announced the launch of the Shield™ multi-cancer ...
India-based Zydus Lifesciences has announced that its innovative drug Desidustat tablets, licensed to the subsidiary of ...
LabConnect, a leading provider of technology-driven central laboratory services and functional service provider sol...
Codex Genetics, a leading precision diagnostics company headquartered in Hong Kong, has announced a strategic collaborat...
Hong Kong-based CK Life Sciences has announced the establishment of Sequencio Therapeutics, a wholly-owned subsidiary de...
Beijing Tsingke Biotech and iGeneTech Bioscience have announced a strategic partnership aimed at advancing the fiel...
Hangzhou Sciwind Biosciences has announced that China's National Medical Products Administration (NMPA) has approved Ecn...
MGI Tech Co., Ltd. , a company dedicated to developing core tools and technologies that drive innovation in the life sci...
The Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and t...
China-based WuXi XDC Cayman Inc. (WuXi XDC), a leading global CRDMO (Contract Research, Development, and Manufacturing O...
China-based Frontier Biotechnologies Inc. has entered into an exclusive licensing agreement with GSK, a global biop...
The InnoHK Centre for Neuromusculoskeletal Restorative Medicine (CNRM), established by The Chinese University of Hong Ko...
Shanghai Junshi Biosciences Co., Ltd, a leading innovation-driven biopharmaceutical company dedicated to the discovery, ...
Hangzhou Sciwind Biosciences has announced a strategic commercialisation collaboration with Pfizer China for Ecnoglutide...
QuidelOrtho has entered a long-term strategic supply agreement with China's Lifotronic Technology, to expand QuidelOrtho...
CARsgen Therapeutics, a company focused on developing innovative CAR T-cell therapies, has announced that through its in...
Madrigal Pharmaceuticals, Inc., a US-based biopharmaceutical company focused on delivering novel therapeutics for metabo...
China-based Innovent Biologics, Inc. has announced a strategic collaboration with Eli Lilly and Company, in the US, to a...
The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Dete...
In response to the growing demand amid Hong Kong’s rapidly ageing population for healthcare professionals such as ...
Frontage Laboratories, Inc., a global Contract Research, Development and Manufacturing Organization (CRDMO), has announc...
AstraZeneca strengthens its weight management portfolio through a new strategic collaboration agreement with China-based...
AstraZeneca has announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D. Th...
WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio I...
China-based Simcere Pharmaceutical Group and Germany-headquartered Boehringer Ingelheim have announced a license and col...